Literature DB >> 23824828

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Alida L P Caforio1, Sabine Pankuweit, Eloisa Arbustini, Cristina Basso, Juan Gimeno-Blanes, Stephan B Felix, Michael Fu, Tiina Heliö, Stephane Heymans, Roland Jahns, Karin Klingel, Ales Linhart, Bernhard Maisch, William McKenna, Jens Mogensen, Yigal M Pinto, Arsen Ristic, Heinz-Peter Schultheiss, Hubert Seggewiss, Luigi Tavazzi, Gaetano Thiene, Ali Yilmaz, Philippe Charron, Perry M Elliott.   

Abstract

In this position statement of the ESC Working Group on Myocardial and Pericardial Diseases an expert consensus group reviews the current knowledge on clinical presentation, diagnosis and treatment of myocarditis, and proposes new diagnostic criteria for clinically suspected myocarditis and its distinct biopsy-proven pathogenetic forms. The aims are to bridge the gap between clinical and tissue-based diagnosis, to improve management and provide a common reference point for future registries and multicentre randomised controlled trials of aetiology-driven treatment in inflammatory heart muscle disease.

Entities:  

Keywords:  Cardiomyopathy; Diagnosis; Myocarditis; Therapy

Mesh:

Substances:

Year:  2013        PMID: 23824828     DOI: 10.1093/eurheartj/eht210

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  722 in total

1.  Disrespectful thoughts on dimensions in the outer and inner world.

Authors:  H Stormorken
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 2.  What's new in myocarditis?

Authors:  Charles-Edouard Luyt; Guillaume Hékimian; Fredric Ginsberg
Journal:  Intensive Care Med       Date:  2015-08-14       Impact factor: 17.440

3.  Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.

Authors:  Roderick Tung; Brenton Bauer; Heinrich Schelbert; Joseph P Lynch; Martin Auerbach; Pawan Gupta; Christiaan Schiepers; Samantha Chan; Julie Ferris; Martin Barrio; Olujimi Ajijola; Jason Bradfield; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2015-08-10       Impact factor: 6.343

4.  Foreword to special issue on "Myocarditis".

Authors:  Alida L P Caforio
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

5.  A case of myopericarditis caused by Neisseria meningitidis W135 serogroup with protracted inflammatory syndrome.

Authors:  Alex J Keeley; Daniel Hammersley; Sukhbir S Dhamrait
Journal:  Clin Med (Lond)       Date:  2018-06       Impact factor: 2.659

Review 6.  Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis.

Authors:  Chrysanthos Grigoratos; Gianluca Di Bella; Giovanni Donato Aquaro
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

7.  Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.

Authors:  Shira Peleg Hasson; Benjamin Salwen; Ayelet Sivan; Sivan Shamai; Ravit Geva; Ofer Merimsky; Ari Raphael; Haim Shmilovich; Yonatan Moshkovits; Livia Kapusta; Zach Rozenbaum; Ido Wolf; Michal Laufer-Perl
Journal:  Clin Res Cardiol       Date:  2020-04-15       Impact factor: 5.460

Review 8.  Cardio-toxicity of checkpoint inhibitors.

Authors:  Oliver J Müller; Martina E Spehlmann; Norbert Frey
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

9.  Metformin protects against infection-induced myocardial dysfunction.

Authors:  Theodora Tzanavari; Aimilia Varela; Stamatis Theocharis; Elpinickie Ninou; Alkistis Kapelouzou; Dennis V Cokkinos; Maria I Kontaridis; Katia P Karalis
Journal:  Metabolism       Date:  2016-07-09       Impact factor: 8.694

10.  Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart.

Authors:  Nicola L Diny; Xuezhou Hou; Jobert G Barin; Guobao Chen; Monica V Talor; Julie Schaub; Stuart D Russell; Karin Klingel; Noel R Rose; Daniela Čiháková
Journal:  Eur J Immunol       Date:  2016-10-25       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.